D.E. Shaw & Co’s Corazon Capital V838 Monoceros Corp Class A Ordinary Shares CRZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-897,276
Closed -$9.06M 5097
2022
Q4
$9.06M Buy
897,276
+33,333
+4% +$333K 0.01% 1524
2022
Q3
$8.56M Buy
863,943
+132,100
+18% +$1.3M 0.01% 1481
2022
Q2
$7.17M Buy
731,843
+50,000
+7% +$490K 0.01% 1728
2022
Q1
$6.67M Sell
681,843
-320,000
-32% -$3.11M 0.01% 1999
2021
Q4
$9.78M Buy
1,001,843
+251,843
+34% +$2.45M 0.01% 1685
2021
Q3
$7.26M Buy
750,000
+598,791
+396% +$5.81M 0.01% 1780
2021
Q2
$1.47M Buy
+151,209
New +$1.47M ﹤0.01% 3237

Other funds holding CRZN

D.E. Shaw & Co's CRZN Position: Q1 2023 in Review

D.E. Shaw & Co sold out of Corazon Capital V838 Monoceros Corp Class A Ordinary Shares (CRZN) in Q1 2023, closing a stake of 897,276 shares — an estimated $9.06M sold.

D.E. Shaw & Co first reported a position in CRZN in Q2 2021 and held it in 7 quarters. The position peaked at $9.78M in Q4 2021. 1 fund tracked by Wall St. Rank holds CRZN as of Q1 2023.

  • D.E. Shaw & Co reported no remaining Corazon Capital V838 Monoceros Corp Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • D.E. Shaw & Co sold 897,276 Corazon Capital V838 Monoceros Corp Class A Ordinary Shares shares in Q1 2023, an estimated $9.06M.
  • D.E. Shaw & Co first reported a position in Corazon Capital V838 Monoceros Corp Class A Ordinary Shares in Q2 2021 and held it in 7 quarters.
  • D.E. Shaw & Co's Corazon Capital V838 Monoceros Corp Class A Ordinary Shares position peaked at $9.78M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Corazon Capital V838 Monoceros Corp Class A Ordinary Shares as of Q1 2023.

Based on D.E. Shaw & Co's 13F filing for Q1 2023, filed 15 May 2023.